Diese Seite ist nicht auf Deutsch verfügbar. Hier gelangen Sie zur deutschen Homepage.
This page isn’t available in English. Here, you’ll get to the English homepage.
このページには日本語版がございません。
Esta página no está disponible en español - Aquí podrá acceder a la página web en español.
Questa pagina non è disponibile in italiano. Qui si accede alla homepage in italiano.
Cette page n’est pas disponible en français. Ce lien vous conduira à la page d'accueil en français.
해당 페이지는 한국어가 지원되지 않습니다. 이 곳을 클릭하시면 한국어 버전 홈페이지로 이동하게 됩니다.
Thorsten Bausch, European and German patent attorney, partner and member of HOFFMANN EITLE's chemistry group, has written an article on the apparent difficulty of pharma patents to survive revocation proceedings before...
read moreWith its Newsletter 02/2008, HOFFMANN EITLE already provided general information on the fee increases scheduled by the EPO. ...
read moreOn 25 January 2008, the UK Patents Court issued a decision in Astron Clinica and Others, which has changed the way in which the UK Intellectual Property Office treats the allowability...
read moreEPO to discourage tall stories and wild claims – applicants should prepare now, if they want to enjoy a foolproof April 1st 2009 ...
read more
Hoffmann Eitle
